...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this

I don't see pockets being lined just the superb management skills that Toinvest and others have been pointing out for a number of years.

tada 

Share
New Message
Please login to post a reply